Hong GS, Park SH, Kim B, Lee JH, Kim JC, Yu CS, Baek S, Lee JS, Kim HJ Simethicone to prevent colonic bubbles during CT colonography performed with polyethylene glycol lavage and iohexol tagging: a randomized clinical trial. AJR Am J Roentgenol. 2015 Apr;204(4):W429-38. doi: 10.2214/AJR.14.13024.
Horton KM, Fishman EK, Gayler B The use of iohexol as oral contrast for computed tomography of the abdomen and pelvis. J Comput Assist Tomogr. 2008 Mar-Apr;32(2):207-9. doi: 10.1097/RCT.0b013e3180674e44.
Kim B, Park SH, Hong GS, Lee JH, Lee JS, Kim HJ, Kim AY, Ha HK Iohexol versus diatrizoate for fecal/fluid tagging during CT colonography performed with cathartic preparation: comparison of examination quality. Eur Radiol. 2015 Jun;25(6):1561-9. doi: 10.1007/s00330-014-3568-0. Epub 2015 Jan 11.
McNamara MM, Lockhart ME, Fineberg NS, Berland LL Oral contrast media for body CT: Comparison of diatrizoate sodium and iohexol for patient acceptance and bowel opacification. AJR Am J Roentgenol. 2010 Nov;195(5):1137-41. doi: 10.2214/AJR.09.3968.
Munikrishnan V, Gillams AR, Lees WR, Vaizey CJ, Boulos PB Prospective study comparing multislice CT colonography with colonoscopy in the detection of colorectal cancer and polyps. Dis Colon Rectum. 2003 Oct;46(10):1384-90. doi: 10.1007/s10350-004-6755-2.
Muto T, Bussey HJ, Morson BC The evolution of cancer of the colon and rectum. Cancer. 1975 Dec;36(6):2251-70. doi: 10.1002/cncr.2820360944.
Park SH, Yee J, Kim SH, Kim YH Fundamental elements for successful performance of CT colonography (virtual colonoscopy). Korean J Radiol. 2007 Jul-Aug;8(4):264-75. doi: 10.3348/kjr.2007.8.4.264.
Peterson CM, Lin M, Pilgram T, Heiken JP Prospective randomized trial of iohexol 350 versus meglumine sodium diatrizoate as an oral contrast agent for abdominopelvic computed tomography. J Comput Assist Tomogr. 2011 Mar-Apr;35(2):202-5. doi: 10.1097/RCT.0b013e3182058e76.
Pickhardt PJ, Taylor AJ, Kim DH, Reichelderfer M, Gopal DV, Pfau PR Screening for colorectal neoplasia with CT colonography: initial experience from the 1st year of coverage by third-party payers. Radiology. 2006 Nov;241(2):417-25. doi: 10.1148/radiol.2412052007. Epub 2006 Sep 18.
Pollentine A, Ngan-Soo E, McCoubrie P Acceptability of oral iodinated contrast media: a head-to-head comparison of four media. Br J Radiol. 2013 May;86(1025):20120636. doi: 10.1259/bjr.20120636.
Siegel RL, Miller KD, Jemal A Cancer statistics, 2015. CA Cancer J Clin. 2015 Jan-Feb;65(1):5-29. doi: 10.3322/caac.21254. Epub 2015 Jan 5.
U S. Food and Drug Administration. Omnipaque (iohexol) injection. Available via http:// www.accessdata.fda.gov/drugsatfda_docs/label/2015/018956s095,020608s031lbl.pdf. Accessed July 16, 2015
Zalis ME, Perumpillichira J, Del Frate C, Hahn PF CT colonography: digital subtraction bowel cleansing with mucosal reconstruction initial observations. Radiology. 2003 Mar;226(3):911-7. doi: 10.1148/radiol.2263012059. Epub 2003 Jan 24.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.